Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Ilana, Bergelson"'
Publikováno v:
Current Urology Reports. 23:319-325
Objective measures of residency applicants do not correlate to success within residency. While industry and business utilize standardized interviews with blinding and structured questions, residency programs have yet to uniformly incorporate these te
Autor:
Annette Scheid, Francesco Borriello, Carlo Pietrasanta, Helen Christou, Joann Diray-Arce, Matthew A. Pettengill, Sweta Joshi, Ning Li, Ilana Bergelson, Tobias Kollmann, David J. Dowling, Ofer Levy
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Immunization is key to protecting term and preterm infants from a heightened risk of infection. However, preterm immunity is distinct from that of the term, limiting its ability to effectively respond to vaccines routinely given at birth, such as hep
Externí odkaz:
https://doaj.org/article/85da4ce05e644b358a962d00c8db1386
Autor:
David J. Dowling, Holly Sanders, Wing Ki Cheng, Sweta Joshi, Spencer Brightman, Ilana Bergelson, Carlo Pietrasanta, Simon Daniel Van Haren, Sandra van Amsterdam, Jeffrey Fernandez, Germie P.J.M. van den Dobbelsteen, Ofer Levy
Publikováno v:
Frontiers in Immunology, Vol 7 (2016)
Background. Group B Neisseria meningitidis, an endotoxin-producing gram-negative bacterium, causes the highest incidence of group B meningococcus (MenB) disease in the first year of life. The Bexsero vaccine is indicated in Europe from 8 weeks of age
Externí odkaz:
https://doaj.org/article/429d5895912a45e697300e6c6b16774e
Autor:
Eva Guinan, David E Avigan, Robert J Soiffer, Nancy J Bunin, Lisa L Brennan, Ilana Bergelson, Spencer Brightman, Al Ozonoff, Patrick J Scannon, Ofer Levy
Publikováno v:
F1000Research, Vol 4 (2015)
Bacterial infection and inflammation contribute significantly to the morbidity and mortality of myeloablative allogeneic hematopoietic cell transplantation (HCT). Endotoxin, a component of the outer membrane of Gram-negative bacteria, is a potent inf
Externí odkaz:
https://doaj.org/article/38a21c9830564e2d829e4fd9bc79c3cd
Autor:
Lakshmi Ganapathi, Simon Van Haren, David J Dowling, Ilana Bergelson, Nikunj M Shukla, Subbalakshmi S Malladi, Rajalakshmi Balakrishna, Hiromi Tanji, Umeharu Ohto, Toshiyuki Shimizu, Sunil A David, Ofer Levy
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0134640 (2015)
Newborns and young infants are at higher risk for infections than adults, and manifest suboptimal vaccine responses, motivating a search for novel immunomodulators and/or vaccine adjuvants effective in early life. In contrast to most TLR agonists (TL
Externí odkaz:
https://doaj.org/article/696380fd21fe44ccb21fccde2a8a3ea0
Publikováno v:
Videourology. 34
Introduction: Focal therapy of prostate cancer aims to destroy known cancer while preserving uninvolved prostatic tissue with the goal of preserving genitourinary function.1,2 Previous methods of f...
Autor:
Krishnanath Gaitonde, Monzer Haj-Hamed, Ilana Bergelson, Connor Hoge, Sadhna Verma, Abhinav Sidana, Sean Maynor, Daniel J. Lama
Publikováno v:
Prostate cancer and prostatic diseases. 23(4)
Black men have significantly higher incidence and are up to three times more likely to die of prostate cancer (PCa) than White men. Multiparametric magnetic resonance imaging-ultrasound fusion biopsy (FBx) has emerged as a promising modality for the
Autor:
Simon D. van Haren, Jason D. Marshall, Ilana Bergelson, Ronald C. Samuels, Michaela Banks, David J. Dowling, Ofer Levy, Steven G. Reed, Lakshmi Ganapathi
Publikováno v:
Cytokine. 83:99-109
Most infections occur in early life, prompting development of novel adjuvanted vaccines to protect newborns and infants. Several Toll-like receptor (TLR) agonists (TLRAs) are components of licensed vaccine formulations or are in development as candid
Autor:
Alvin T. Kho, Sebastian T. Berger, Saima Ahmed, David J. Dowling, Matthew A. Pettengill, Djin-Ye Oh, Hanno Steen, Brightman Spencer E, Ilana Bergelson, Ofer Levy, Hyungwon Choi, Henry Pollack, John F. Sauld
Publikováno v:
Molecular & Cellular Proteomics : MCP
Adjuvants boost vaccine responses, enhancing protective immunity against infections that are most common among the very young. Many adjuvants activate innate immunity, some via Toll-Like Receptors (TLRs), whose activities varies with age. Accordingly
Autor:
Annette Scheid, Francesco Borriello, Carlo Pietrasanta, Helen Christou, Joann Diray-Arce, Matthew A. Pettengill, Sweta Joshi, Ning Li, Ilana Bergelson, Tobias Kollmann, David J. Dowling, Ofer Levy
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 9 (2018)
Frontiers in Immunology, Vol 9 (2018)
Immunization is key to protecting term and preterm infants from a heightened risk of infection. However, preterm immunity is distinct from that of the term, limiting its ability to effectively respond to vaccines routinely given at birth, such as hep